Behcet Syndrome
Information
- Disease name
- Behcet Syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04386824 | Completed | Erectile Dysfunction in Patients With Non Ocular Behçet's Disease | June 15, 2019 | December 15, 2019 | |
NCT00866359 | Completed | Phase 2 | A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease | August 1, 2009 | May 1, 2012 |
NCT00483184 | Completed | Phase 2 | Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease | April 2006 | April 2008 |
NCT01532570 | Completed | Phase 3 | Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions | January 2012 | May 2014 |
NCT05142995 | Completed | Sleep Related Breathing Disorders, Anxiety, Depression and Quality of Life Assessment in Behcet's Disease | September 1, 2021 | March 1, 2023 | |
NCT03264391 | Completed | Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography | March 1, 2018 | January 31, 2020 | |
NCT03274648 | Completed | N/A | Dietary Interventions and Butyrate Production in Behçet's Patients | September 27, 2017 | July 5, 2019 |
NCT03514056 | Completed | Frequency of Fibromyalgia in Behcet Disease | May 30, 2018 | February 28, 2019 | |
NCT05098678 | Completed | N/A | Zinc Supplementation and Behçet's Syndrome | August 22, 2020 | September 22, 2021 |
NCT05032248 | Completed | N/A | Uses of Tacrolimus in Behcet Disease | April 1, 2019 | December 1, 2019 |
NCT04961463 | Completed | N/A | Evaluation of the Psychoeducation Program Given to Behcet's Patients in the Context of the Roy Adaptation Model | September 15, 2016 | May 15, 2018 |
NCT03962335 | Completed | N/A | Gut Microbiota and Behcet's Syndrome: a Dietary Intervention Trial (MAMBA Study) | January 6, 2019 | May 31, 2023 |
NCT04186559 | Not yet recruiting | Phase 2 | Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers | February 2024 | December 2024 |
NCT05200715 | Recruiting | AutoInflammatory Disease Alliance Registry (AIDA) | August 6, 2020 | August 6, 2030 | |
NCT03554161 | Terminated | Phase 2 | Tocilizumab for the Treatment of Refractory Behcet's Uveitis | May 10, 2018 | February 1, 2021 |
NCT01693653 | Terminated | Phase 2 | Tocilizumab for the Treatment of Behcet's Syndrome | September 2012 | November 2013 |
NCT04218565 | Terminated | Phase 2 | Golimumab for the Treatment of Refractory Behcet's Uveitis | February 15, 2020 | December 15, 2022 |
NCT00931957 | Unknown status | N/A | Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease | October 2010 | October 2013 |
NCT03747354 | Unknown status | N/A | Assessment of Disease Activity in Behcet by Complete Blood Count | December 2018 | October 2019 |
NCT04738864 | Unknown status | N/A | Neuro-ultrasound Assessment in Behcet's Disease | March 2021 | August 2021 |
NCT03771768 | Unknown status | N/A | Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease | May 25, 2019 | May 25, 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001528